Metabolyz review
Metabolyz combines clinician review with nutrition, movement and lifestyle coaching, but keeps program prices inside consultation.
The verdict
The coaching model is more specific than prescription delivery alone. Its value depends on the actual contact schedule and the total quoted fee; neither the projected weight curve nor testimonials establish durable results for an individual.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Metabolyz is a telehealth access platform operated by The Westview Drive Co Inc. It describes semaglutide and tirzepatide programs with ongoing coaching.
Who writes the prescription, and what do they see?
The terms separate the platform from independent clinicians and pharmacies. Ask for the treating practice and dispenser before consenting; the platform’s medical-supervision language is not the name of your prescriber.
An online consultation precedes clinical authorization. The site describes structured check-ins and direct messages to the care team, with nutrition and movement support alongside medication.
What happens when the dose goes up?
The semaglutide page describes provider-directed adjustments and messaging between check-ins. It does not specify a universal appointment frequency. Establish how symptoms and refill requests are reviewed before each shipment.
What the price includes
The FAQ explicitly withholds public pricing and says the quote depends on protocol and program length. A monthly membership description alone does not reveal the total or whether a dose change changes it.
What it claims, and what it cites
The site identifies compounded semaglutide and tirzepatide pathways. Compounded drugs are not FDA-approved. Its separate microdose and longevity marketing does not establish additional proven benefits.
Where it holds up, and where it does not
- Strength: Nutrition and movement coaching described
- Strength: Direct care-team messaging
- Limitation: Prices withheld until consultation
- Limitation: Visit frequency needs confirmation
What the evidence says about this kind of treatment
The assessment above is about Metabolyz. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone comparing a medication-plus-coaching service and willing to obtain a detailed quote first.
- Wrong for
- Someone who needs a published dose-specific price and a fixed visit schedule before sharing an intake.
The evidence behind what Metabolyz prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Metabolyz compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: DreamHug MedicalDudeMedsEclipse Medical WellnessEdessaEdgeRxEffecty
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Who makes prescribing decisions?
- Independent licensed clinicians, rather than the platform company, decide whether and what to prescribe.
- Does the projected weight curve predict my outcome?
- No. A marketing projection is not an individualized clinical assessment or verified program outcome.
Sources for this review
Provider information checked . Terms can change.